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First, Kwong et al. point out that our study is a meta-analysis of randomized studies, questioning the inclusion of NOBORI Core and TIVOLI studies which, indeed, are non-randomized trials. 2, 3 Our meta-analysis aimed to summarize the most complete information available in a field in which published data is rather limited. When the question of interest cannot be answered only by the inclusion of randomized trials, authors may be justified in including non-randomized studies. 4 In such cases, every effort should be made to explore and mitigate heterogeneity, considering prespecified covariates as potential confounders in metaregression analysis, using a more conservative random model in odds ratio calculations, and performing subgroup analyses limited to the more homogeneous subgroup of patients (in our study we pre-specified a subgroup with only randomized controlled trials). 5 This approach was pre-specified in the 'Methods' section of our paper and was done in our analysis, obtaining results substantially similar to the main analysis. 1 Secondly, Kwong et al. observed that data of the ISAR-TEST-3 two-year follow-up report 6 were pooled with other studies reporting angiographic data at 6-9 months and clinical follow up data at one year. This was done with the purpose of extending the follow-up of subjects observed for rare clinical events, given the paucity of data regarding the late stent thrombosis. This actually had no significant impact on the results of the analysis, as demonstrated in Figure 1 where the analyses were conducted using the shorter follow up data.
Finally, Kwong et al. correctly observed that in Figure 1 we reported a wrong figure of 11 trials excluded, while in Table 2 we correctly listed 12 studies. We also agree with the observation that the number of included studies should have been eight, while the figure of 10 refers to the included reports, and that the latest citation of the Cochrane handbook is March 2011. However these minor inaccuracies do not substantially change the figures of our analysis.
We greatly appreciate the interest of our colleagues in our work and we are grateful for the opportunity they gave us to further clarify it. We also agree that minor formal details are important to maintain a high degree of quality of a meta-analytic study. However, taking into account Kwong et al.'s criticisms and suggestions did not change substantially our results and further strengthened the global message of our study.
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